Capitol Hill House oversight committee threatens to subpoena NIH documents in sexual misconduct investigation October 20, 2023Vol.49 No.39By Matthew Bin Han Ong
FreeObituary Franklyn Prendergast, first Black director of an NCI-designated cancer center, was a role model to minority physicians October 20, 2023Vol.49 No.39By Otis W. Brawley and Robert A. Winn
FreeObituary Mayo’s Franklyn Prendergast dies at 78 October 20, 2023Vol.49 No.39By Audrey Laine Seymour
FreeIn the Archives Remembering Franklyn Prendergast: His 2021 Mayo Clinic commencement speech October 20, 2023Vol.49 No.39
NCI NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria October 13, 2023Vol.49 No.38By Alexandria Carolan and Paul Goldberg
Robert Winn introduces “Inclusive Excellence” as his AACI presidential initiative“If we’re going to be inclusive, then we need to be inclusive.” October 13, 2023Vol.49 No.38By Alexandria Carolan
Health Equity Cancer centers must focus on measurable endpoints in building a diverse workforce, improving health equity October 13, 2023Vol.49 No.38By Matthew Bin Han Ong
Carpten, Diaz, Elenitoba-Johnson, Leach, Merad, Mukherjee, Newman, Vonderheide, and Wolchok are among NAM 100 new members October 13, 2023Vol.49 No.38
Real-world Evidence Real-world tumor response rate can serve as a clinical endpoint, Friends pilot study showsFDA says raw images enrich the data when used with clinician assessments October 06, 2023Vol.49 No.37By Matthew Bin Han Ong
Regulatory News ODAC vote on sotorasib signals FDA intent to confront perceived loss of equipoise in cancer clinical trials October 06, 2023Vol.49 No.37By Jacquelyn Cobb and Paul Goldberg
